Your browser doesn't support javascript.
loading
Children Born Small for Gestational Age: Differential Diagnosis, Molecular Genetic Evaluation, and Implications.
Finken, Martijn J J; van der Steen, Manouk; Smeets, Carolina C J; Walenkamp, Marie J E; de Bruin, Christiaan; Hokken-Koelega, Anita C S; Wit, Jan M.
Affiliation
  • Finken MJJ; Department of Pediatrics, VU University Medical Center, MB Amsterdam, Netherlands.
  • van der Steen M; Department of Pediatrics, Erasmus University Medical Center/Sophia Children's Hospital, CN Rotterdam, Netherlands.
  • Smeets CCJ; Department of Pediatrics, Erasmus University Medical Center/Sophia Children's Hospital, CN Rotterdam, Netherlands.
  • Walenkamp MJE; Department of Pediatrics, VU University Medical Center, MB Amsterdam, Netherlands.
  • de Bruin C; Department of Pediatrics, Leiden University Medical Center, RC Leiden, Netherlands.
  • Hokken-Koelega ACS; Department of Pediatrics, Erasmus University Medical Center/Sophia Children's Hospital, CN Rotterdam, Netherlands.
  • Wit JM; Department of Pediatrics, Leiden University Medical Center, RC Leiden, Netherlands.
Endocr Rev ; 39(6): 851-894, 2018 12 01.
Article in En | MEDLINE | ID: mdl-29982551
Children born small for gestational age (SGA), defined as a birth weight and/or length below -2 SD score (SDS), comprise a heterogeneous group. The causes of SGA are multifactorial and include maternal lifestyle and obstetric factors, placental dysfunction, and numerous fetal (epi)genetic abnormalities. Short-term consequences of SGA include increased risks of hypothermia, polycythemia, and hypoglycemia. Although most SGA infants show catch-up growth by 2 years of age, ∼10% remain short. Short children born SGA are amenable to GH treatment, which increases their adult height by on average 1.25 SD. Add-on treatment with a gonadotropin-releasing hormone agonist may be considered in early pubertal children with an expected adult height below -2.5 SDS. A small birth size increases the risk of later neurodevelopmental problems and cardiometabolic diseases. GH treatment does not pose an additional risk.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Infant, Small for Gestational Age / Growth Hormone / Dwarfism / Infant, Newborn, Diseases Type of study: Diagnostic_studies Limits: Humans / Newborn Language: En Journal: Endocr Rev Year: 2018 Document type: Article Affiliation country: Netherlands Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Infant, Small for Gestational Age / Growth Hormone / Dwarfism / Infant, Newborn, Diseases Type of study: Diagnostic_studies Limits: Humans / Newborn Language: En Journal: Endocr Rev Year: 2018 Document type: Article Affiliation country: Netherlands Country of publication: United States